Citations

Showing 10 of 108094 citations.

Response to: ‘Congenital tricuspid valve disease can masquerade as primary idiopathic TR’ by Rajpal
Fender, Erin A. , Zack, Chad, Nishimura, Rick A., Fender, Erin Amanda , Zack, Chad J

Mayo Clinic

Heart | February 24, 2018 | Volume: 104 | Issue: 15 | Pages: 1308-1308

10.1136/heartjnl-2018-313078 | PMID 29478037 Get It

Research Imaging of Brain Structure and Function After Concussion
Chong, Catherine D. , Schwedt, Todd J. , Chong, Catherine D

Mayo Clinic

Headache: The Journal of Head and Face Pain | February 24, 2018 | Volume: 58 | Issue: 6 | Pages: 827-835

10.1111/head.13269 | PMID 29476532 Get It

Even when concussions are associated with prolonged physical and cognitive sequelae, concussions are typically “invisible” on diagnostic brain imaging, indicating that the neuropathology associated with concussion lies under the detection threshold of routine imaging. However, data from brain structural and functional research imaging studies using diffusion tensor imaging, resting‐state functional magnetic resonance imaging, and brain perfusion imaging indicate that these imaging sequences have a role in identifying concussion‐related neuropathology. These advanced imaging techniques provide insights into concussion neuropathology and might be useful for differentiating concussed patients from healthy controls. In this review article, we provide an overview of research findings from brain structural and functional imaging studies of concussion, and discuss the accuracy of classification models developed via machine‐learning algorithms for identifying individual patients with concussion based on imaging data.
Isoform-level gene expression patterns in single-cell RNA-sequencing data
Vu, Trung Nghia , Wills, Quin F., Niu, Nifang, Wang, Liewei , Rantalainen, Mattias , Kalari, Krishna R. , Pawitan, Yudi

Mayo Clinic

Bioinformatics | February 23, 2018 | Volume: 34 | Issue: 14 | Pages: 2392-2400

10.1093/bioinformatics/bty100 | PMID 29490015 Get It

Abstract Motivation RNA sequencing of single cells enables characterization of transcriptional heterogeneity in seemingly homogeneous cell populations. Single-cell sequencing has been applied in a wide range of researches fields. However, few studies have focus on characterization of isoform-level expression patterns at the single-cell level. In this study, we propose and apply a novel method, ISOform-Patterns (ISOP), based on mixture modeling, to characterize the expression patterns of isoform pairs from the same gene in single-cell isoform-level expression data. Results We define six principal patterns of isoform expression relationships and describe a method for differential-pattern analysis. We demonstrate ISOP through analysis of single-cell RNA-sequencing data from a breast cancer cell line, with replication in three independent datasets. We assigned the pattern types to each of 16 562 isoform-pairs from 4929 genes. Among those, 26% of the discovered patterns were significant (P<0.05), while remaining patterns are possibly effects of transcriptional bursting, drop-out and stochastic biological heterogeneity. Furthermore, 32% of genes discovered through differential-pattern analysis were not detected by differential-expression analysis. Finally, the effects of drop-out events and expression levels of isoforms on ISOP's performances were investigated through simulated datasets. To conclude, ISOP provides a novel approach for characterization of isoform-level preference, commitment and heterogeneity in single-cell RNA-sequencing data. Availability and implementation The ISOP method has been implemented as a R package and is available at https://github.com/nghiavtr/ISOP under a GPL-3 license. Supplementary information Supplementary data are available at Bioinformatics online.
No handshake agreement on postural tremor subtypes in Parkinson disease?
Hassan, Anhar

Mayo Clinic

Neurology | February 23, 2018 | Volume: 90 | Issue: 13 | Pages: 581-582

10.1212/wnl.0000000000005199 | PMID 29476034 Get It

Internet Use by Gynecologic Oncology Patients and Its Relationship with Anxiety
Corrales, Dalia M, Wells, Ali , Breitkopf, Carmen Radecki , Peña, Gabriela de la, Kaplan, Alan L., King, Lorrie S, Robazetti, Sonia C., Dinh, Tri A., Wells, Ali E, Radecki Breitkopf, Carmen, Corrales, Dalia M

Mayo Clinic

Journal of Health Communication | February 23, 2018 | Volume: 23 | Issue: 3 | Pages: 299-305

10.1080/10810730.2018.1442529 | PMID 29474124 Get It

Anticholinergic Medications and Cognitive Function in Late Midlife
Limback-Stokin, Martin M. , Roesler, Kimberly, Hansen, Allison , Stonnington, Cynthia M. , Temkit, M’hamed, Caselli, Richard J. , Geda, Yonas E. , Krell-Roesch, Janina, Geda, Yonas E , Krell‐Roesch, Janina

Mayo Clinic

Alzheimer Disease & Associated Disorders | February 23, 2018 | Volume: 32 | Issue: 3 | Pages: 262-264

10.1097/wad.0000000000000251 | PMID 29481373 Get It

Presence of autoimmune disease affects not only risk but also survival in patients with B‐cell non‐Hodgkin lymphoma
Kleinstern, Geffen , Averbuch, Mor, Seir, Rania Abu , Perlman, Riki , Yehuda, Dina Ben , Paltiel, Ora , Abu Seir, Rania

Mayo Clinic

Hematological Oncology | February 23, 2018 | Volume: 36 | Issue: 2 | Pages: 457-462

10.1002/hon.2498 | PMID 29469175 Get It

AbstractAlthough autoimmune diseases (AIDs) are known to predispose to non‐Hodgkin lymphoma (NHL), their association with NHL prognosis has rarely been investigated. We examined associations between autoimmunity and B‐cell NHL onset by comparing AID history (determined by self‐report and medication review and supplemented by chart review where possible) among 435 adult B‐NHL patients in Hadassah‐Hebrew University Medical Center, diagnosed 2009‐2014, and 414 age‐and‐sex frequency‐matched controls. We examined AIDs as a whole, B‐ and T‐cell–mediated AIDs, and autoimmune thyroid diseases. Among cases, we used Kaplan‐Meier and Cox regression models to assess the association of AID with overall survival and relapse‐free survival, adjusting for prognostically important patient and disease characteristics such as Ki67% staining, International Prognostic Index, rituximab treatment, and histological subgroup.Autoimmune diseases were associated with B‐NHL (odds ratio [OR] = 1.95; 95% confidence interval (CI), 1.31‐2.92), especially AIDs mediated by B‐cell activation (OR = 5.20; CI, 1.90‐14.3), which were particularly associated with marginal zone lymphoma (OR = 19.3; CI, 4.59‐80.9). We found that time to relapse for all B‐NHL patients with AIDs was significantly shorter (mean of 49.21 mo [±3.22]) than among patients without AID (mean of 59.74 mo [±1.62]), adjusted hazard ratio [HRadj] = 1.69 (CI, 1.03‐2.79). Specifically, in patients with diffuse large B‐cell lymphoma, of whom 91.8% had received rituximab, a history of B‐cell–mediated AIDs was associated with shorter relapse‐free survival and overall survival, HRadj = 8.34 (CI, 3.01‐23.1) and HRadj = 3.83 (CI, 1.20‐12.3), respectively.Beyond confirming the well‐known association between AIDs and B‐NHL, we found that AID is an adverse prognostic factor in B‐cell lymphoma, associated with a shortened time to relapse, suggesting that there are specific therapeutic challenges in the subgroup of patients suffering from both these diseases. Further work is required to address mechanisms of resistance to standard treatment in the setting of AID‐associated B‐NHL. In the era of immunotherapy, these findings have particular relevance.
Validation of a dynamic joint contracture measuring device in a live rabbit model of arthrofibrosis
Reina, Nicolas , Trousdale, William H. , Salib, Christopher G. , Evertz, Loribeth Q., Berglund, Lawrence J., Wijnen, André J. van , Hewett, Timothy E. , Berry, Daniel J., Berry, Daniel J. , Berry, Charlotte E. , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Berry, Daniel J , Berry, Daniel J., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Journal of Orthopaedic Research | February 23, 2018 | Volume: 36 | Issue: 8 | Pages: 2186-2192

10.1002/jor.23884 | PMID 29473666 Get It

ABSTRACTThe current method of measuring arthrofibrosis in live rabbits is critically limited. Specifically, this method involves radioactive fluoroscopy, error‐prone goniometric measurements, and static joint angle outcomes that fail to approximate the compliance of tissues surrounding the joint. This study aims to validate a novel method of capturing the compliance of contracted tissues surrounding the joint without the use of fluoroscopy or animal sacrifice. Surgically induced contractures of one‐hundred and eight rabbits were measured using the current standard of contracture measurement (a pulley system) as well as a newly designed dynamic load cell (DLC) device. The DLC device was highly reliable when compared to the pulley system (r = 0.907, p < 0.001). Finally, the DLC device produced joint stiffness hysteresis curves capable of approximating the compliance of stiff joint tissues, ultimately calculating a mean joint stiffness of 1.57 ± 1.31 N · m · rad−1 (range, 0.33–6.37 N · m · rad−1). In conclusion, the DLC device represents a valid method for measuring joint contractures. Further, the DLC device notably improves current techniques by introducing the capacity to approximate the compliance of contracted tissues in living rabbits. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2186–2192, 2018.
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
King, Rebecca L. , Jiang, Aixiang , Horn, Heike , Mottok, Anja , Farinha, Pedro , Slack, Graham W. , Ennishi, Daisuke , Schmitz, Norbert , Pfreundschuh, Michael , Nowakowski, Grzegorz S. , Gascoyne, Randy D. , Ott, German , Macon, William R. , Rosenwald, Andreas , Scott, David W. , Staiger, Annette M. , Ben‐Neriah, Susana , Kahl, Brad S. , Connors, Joseph M. , Farinha, Pedro

Mayo Clinic

Blood | February 23, 2018 | Volume: 131 | Issue: 18 | Pages: 2060-2064

10.1182/blood-2017-12-820605 | PMID 29475959 Get It

Key Points HGBL-DH/TH makes up 8% of de novo DLBCL, with HGBL-DH/TH with BCL2 rearrangement being a GCB phenomenon. Restricting FISH testing to tumors with dual protein expression and GCB subtype results in testing <15% of tumors, but missing ∼35% of HGBL-DH/TH.
A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
Perwein, Maria Katharina Elisabeth , Smestad, John , Warrington, Arthur E. , Heider, Robin M., Kaczor, Mark W., Maher, L. James , Wootla, Bharath , Kunbaz, Ahmad , Rodriguez, Moses , Perwein, Maria K, Smestad, John A, III, Louis James Maher , Wootla, Bharath , Rodriguez, Moses , Smestad, John

Mayo Clinic

Expert Opinion on Biological Therapy | February 23, 2018 | Volume: 18 | Issue: 5 | Pages: 545-560

10.1080/14712598.2018.1441284 | PMID 29460650 Get It